Price (delayed)
$11.96
Market cap
$225.01M
P/E Ratio
49.83
Dividend/share
N/A
EPS
$0.24
Enterprise value
$158.7M
brainsway is a leading global neurmodulation company with headquarters in jerusalem and the us. our patented breakthrough technology has already treated over 10,000 patients, and has helped usher in a
There are no recent dividends present for BWAY.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.